Dna X (SONM) Receivables - Net (2018 - 2026)

Dna X's Receivables - Net history runs 9 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• Quarterly Receivables - Net fell 69.07% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (down 69.07% YoY) and the FY2024 annual result came in at $4.3 million, down 82.85% from the prior year.
• Receivables - Net was $1.5 million for Q1 2026 at Dna X, down from $6.2 million in the prior quarter.
• Across five years, Receivables - Net topped out at $32.0 million in Q3 2023 and bottomed at $1.5 million in Q1 2026.
• A 5-year average of $13.5 million and a median of $11.7 million in 2022 frame the typical range for Receivables - Net.
• Annual changes were most pronounced in 2023 — Receivables - Net soared 402.05% — and 2024, when it tumbled 83.61%.
• Dna X's Receivables - Net stood at $22.5 million in 2022, then grew by 12.23% to $25.3 million in 2023, then slumped by 82.85% to $4.3 million in 2024, then soared by 42.98% to $6.2 million in 2025, then plunged by 75.82% to $1.5 million in 2026.
• Business Quant data shows SONM's Receivables - Net at $1.5 million in Q1 2026, $6.2 million in Q3 2025, and $2.9 million in Q2 2025.